OpenAI is set to significantly reduce the share of its revenue allocated to commercial partners, primarily Microsoft, according to a report by The Information. Currently, Microsoft receives about 20% of OpenAI’s revenue. However, by the end of the decade, that figure is expected to drop to around 8%. The projected reduction could allow OpenAI to retain more than $50 billion in additional revenue, though it remains unclear if that estimate is annual or cumulative.
The companies are also in ongoing discussions regarding server rental costs, a key part of their collaboration, the report noted. These talks could redefine how OpenAI manages its infrastructure expenses as it continues to scale artificial intelligence services globally.
This shift comes as Microsoft and OpenAI announced a non-binding agreement to restructure their partnership, potentially allowing OpenAI to transition into a for-profit company. Under the current arrangement, OpenAI’s nonprofit arm is expected to secure more than $100 billion in funding. This sum represents nearly 20% of the $500 billion valuation OpenAI is targeting in private markets, positioning it as one of the best-financed nonprofit entities worldwide.
Industry experts note that the renegotiated revenue share could dramatically improve OpenAI’s financial independence while still maintaining strategic ties with Microsoft. Such a move underscores the evolving dynamics between the AI research leader and its largest backer, especially as competition in the artificial intelligence sector intensifies.
Neither Microsoft nor OpenAI has publicly commented on the details of the renegotiations. Still, the potential shift highlights the growing importance of cost management and revenue optimization as OpenAI pursues its ambitious long-term growth strategy.


U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Street Poller Media and The Boom of the Street Interview Ad Industry
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
Nvidia Options Price in $280 Billion Earnings Swing
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
SK Hynix Shares Fall as Workers Reject Wage Deal
OpenAI AI Agent Swarm Behind Hugging Face Hack
Mercer International Stock Surges 45% on C$20 Million Canada Funding
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 



